Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Johnson

Showing results (441-450 of 543) with videos related to

Pageof 55
Sort By:
Preventive Medicine|January 1, 1995
The television, school, and family smoking prevention and cessation project. VIII. Student outcomes and mediating variablesB R Flay, T Q Miller, D Hedeker, et al.
Experimental Neurology|October 1, 1993
Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortexA S Fix, J W Horn, K A Wightman, et al.
Journal of Applied Microbiology|August 18, 2012
Test method development to evaluate hot, humid air decontamination of materials contaminated with Bacillus anthracis ∆Sterne and B. thuringiensis Al Hakam sporesT L Buhr, A A Young, Z A Minter, et al.
Pediatrics|January 31, 1998
Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter studyM T Britto, J M Garrett, M A Dugliss, et al.
Family Medicine|May 1, 1992
Teaching family-centered perinatal care in family medicine, Part IJ E Scherger, C Levitt, L S Acheson, et al.
Family Medicine|July 1, 1992
Teaching family-centered perinatal care in family medicine, Part 2J E Scherger, C Levitt, L S Acheson, et al.
The European Respiratory Journal|June 1, 1995
Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatmentP I Shah, A Bush, G J Canny, et al.
Prostaglandins & Other Lipid Mediators|February 17, 1999
Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseasesJ B Travers, R C Murphy, C A Johnson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesisY Pei, L A Barber, R C Murphy, et al.
Journal of Applied Microbiology|August 11, 2015
Test methods and response surface models for hot, humid air decontamination of materials contaminated with dirty spores of Bacillus anthracis ∆Sterne and Bacillus thuringiensis Al HakamT L Buhr, A A Young, H K Barnette, et al.
Pageof 55

Showing results (441-450 of 543) with videos related to

Sort By:
Pageof 55
Preventive Medicine|January 1, 1995
The television, school, and family smoking prevention and cessation project. VIII. Student outcomes and mediating variablesB R Flay, T Q Miller, D Hedeker, et al.
Experimental Neurology|October 1, 1993
Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortexA S Fix, J W Horn, K A Wightman, et al.
Journal of Applied Microbiology|August 18, 2012
Test method development to evaluate hot, humid air decontamination of materials contaminated with Bacillus anthracis ∆Sterne and B. thuringiensis Al Hakam sporesT L Buhr, A A Young, Z A Minter, et al.
Pediatrics|January 31, 1998
Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter studyM T Britto, J M Garrett, M A Dugliss, et al.
Family Medicine|May 1, 1992
Teaching family-centered perinatal care in family medicine, Part IJ E Scherger, C Levitt, L S Acheson, et al.
Family Medicine|July 1, 1992
Teaching family-centered perinatal care in family medicine, Part 2J E Scherger, C Levitt, L S Acheson, et al.
The European Respiratory Journal|June 1, 1995
Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatmentP I Shah, A Bush, G J Canny, et al.
Prostaglandins & Other Lipid Mediators|February 17, 1999
Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseasesJ B Travers, R C Murphy, C A Johnson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesisY Pei, L A Barber, R C Murphy, et al.
Journal of Applied Microbiology|August 11, 2015
Test methods and response surface models for hot, humid air decontamination of materials contaminated with dirty spores of Bacillus anthracis ∆Sterne and Bacillus thuringiensis Al HakamT L Buhr, A A Young, H K Barnette, et al.
Pageof 55